Skip to main
GL

GL Stock Forecast & Price Target

GL Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Globe Life Inc. is forecasting strong growth in its premium collections, with life insurance premiums expected to increase by 4.0%-5% and supplemental health insurance premiums projected to rise between 9%-16% in the coming year. The company has ramped up its marketing efforts, anticipating a 10% increase in leads generated for its exclusive agencies, which aligns with the upward trajectory of net health sales across its subsidiaries. Additionally, favorable mortality experience contributed to significant remeasurement gains, highlighting the company's robust financial health and solidifying management's confidence in achieving their revised EPS estimates of $14.50 for 2025 and $15.05 for 2026.

Bears say

Globe Life Inc. is projecting a modest operating earnings per share growth of only 3% at the midpoint for 2026, significantly impacted by assumption updates in 2025 and declining remeasurement gains in the Life segment, which are expected to drop from $192 million to between $50-$100 million. Additionally, the potential margin pressures from increasing health utilization, along with risks associated with ongoing EEOC reviews and challenges in salesforce recruiting, raise concerns regarding the company's future revenue growth and overall financial stability. Furthermore, the anticipated underwriting margins suggest fundamental profitability strains, particularly in the Health segment, which may not sufficiently support both earnings expectations and investor confidence in the long term.

GL has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globe Life Inc (GL) Forecast

Analysts have given GL a Buy based on their latest research and market trends.

According to 9 analysts, GL has a Buy consensus rating as of Apr 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $169.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $169.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globe Life Inc (GL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.